Skip to main content

Transcriptional co-activator CBP/p300 regulates chondrocyte-specific gene expression via association with Sox9

Chondrocytes are critical components for the precise patterning of a developing skeletal framework and articular joint formation. Sox9 is a key transcription factor that is essential for chondrocyte differentiation and chondrocyte-specific gene expressions; however, the precise transcriptional activation mechanism of Sox9 is not fully understood. Here we demonstrate that Sox9 utilizes CBP/p300 to exert its effects. Sox9 associates with CBP/p300 in chondrocyte cell line SW1353 via its carboxyl termini activation domain in a cell type-specific manner. In promoter assays, CBP/p300 enhances Col2a1, which encodes cartilage-specific type II collagen gene, the promoter activity via Sox9. Chromatin immunoprecipitation shows that p300 is bound to the Col2a1 promoter region. Furthermore, the CBP/Sox9 complex disrupter peptide suppresses Col2a1 gene expression and chondrogenesis from mesenchymal stem cells. These data demonstrate CBP/p300 functions as a coactivator of Sox9 for cartilage tissue-specific gene expression and chondrocyte differentiation.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Takahashi, S., Tsuda, M., Takahashi, Y. et al. Transcriptional co-activator CBP/p300 regulates chondrocyte-specific gene expression via association with Sox9. Arthritis Res Ther 5, 78 (2003). https://doi.org/10.1186/ar879

Download citation

Keywords

  • Col2a1 Gene
  • Chondrocyte Differentiation
  • Cell Line SW1353
  • Joint Formation
  • Line SW1353